BioXcel Therapeutics Announces Pricing of $7.0 Million Public …
NEW HAVEN, Conn., Nov. 22, 2024 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (the “Company”) (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology, …
OFF
BioXcel Therapeutics Announces Pricing Of $7.0 Million Public …
6 days from now
NEW HAVEN, Conn., Nov. 22, 2024 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (the “Company”) (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology, …
bioxceltherapeutics.com
OFF
BioXcel Therapeutics Announces Pricing Of $7.0 Million Public …
6 days from now
21 hours ago · NEW HAVEN, Conn., Nov. 22, 2024 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (the “Company”) (Nasdaq: BTAI), a biopharmaceutical company utilizing …
yahoo.com
OFF
2024-11-22 | BioXcel Therapeutics Announces Pricing Of $7.0 …
6 days from now
1 day ago · NEW HAVEN, Conn., Nov. 22, 2024 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (the “Company”) (Nasdaq: BTAI), a biopharmaceutical company …
stockhouse.com
OFF
BioXcel Therapeutics Prices 5.6M Shares At 48c In Public Offering
6 days from now
1 day ago · BioXcel Therapeutics announced the pricing of an underwritten public offering of 5,600,000 shares of its common stock, par value $0.001 per share and accompanying …
businessinsider.com
OFF
BioXcel Therapeutics Announces Pricing Of $7M Public Offering
6 days from now
BioXcel Therapeutics, Inc. (BTAI) Q3 2024 Earnings Call Transcript BioXcel announces common stock and warrants offering, no amount given BioXcel Therapeutics GAAP EPS of -$0.32 …
msn.com
OFF
BioXcel Therapeutics Announces Pricing Of $7M Public Offering
6 days from now
21 hours ago · BioXcel Therapeutics announces pricing of public offering at $0.48 per share, grossing $7 million.
seekingalpha.com
OFF
BioXcel Therapeutics Reports Third Quarter 2024 Financial Results
6 days from now
Nov 14, 2024 · Net revenue of $1.9 million for the nine months ended September 30, 2024 increased 89% compared to $1.0 million for same period in 2023. The increase in new …
yahoo.com
OFF
BioXcel Therapeutics Announces Pricing Of $7.0 Million
6 days from now
21 hours ago · BioXcel Therapeutics Announces Pricing of $7.0 Million Public Offering. November 22, 2024 08:16 ... Gross proceeds to the Company from the offering are expected to be …
globenewswire.com
OFF
BioXcel Therapeutics Announces Proposed Public Offering
6 days from now
Feb 8, 2024 · In addition, the Company expects to grant the underwriters a 30-day option to purchase up to $9.0 million of additional shares of common stock at the public offering price, …
yahoo.com
OFF
BioXcel Therapeutics Announces Pricing Of $7.0 Million Public …
6 days from now
1 day ago · NEW HAVEN, Conn., Nov. 22, 2024 -- BioXcel Therapeutics, Inc. , a biopharmaceutical company utilizing artificial intelligence approaches to develop …
marketscreener.com
OFF
BioXcel Therapeutics Announces $7M Public Offering
6 days from now
19 hours ago · BioXcel Therapeutics Inc., ... In March, it announced a $25 million registered direct offering. ... the stock price was trading around 55 cents per share, down 3.6% but above its 52 …
hartfordbusiness.com
OFF
BioXcel Therapeutics (BTAI) Announces Pricing Of $7.0 Million …
6 days from now
21 hours ago · BioXcel Therapeutics (BTAI) Announces Pricing of $7.0 Million Public Offering ... today announced the pricing of an underwritten public offering of 5,600,000 shares of its …
streetinsider.com
OFF
BioXcel Therapeutics Announces Pricing Of $7.0 Million Public …
6 days from now
NEW HAVEN, Conn., Nov. 22, 2024 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (the "Company") (NASDAQ:BTAI), a biopharmaceutical company utilizing artificial intelligence …
quantisnow.com
OFF
BioXcel Therapeutics Announces Pricing Of $7.0 Million Public Of
6 days from now
NEW HAVEN, Conn., Nov. 22, 2024 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (the â Companyâ ) ( BTAI), a biopharmaceutical company utilizing artificial i 🚀 Enjoy a 7-Day Free …
gurufocus.com
OFF
BioXcel Therapeutics Announces Pricing Of $7.0 Million Public …
6 days from now
21 hours ago · Each of the accompanying warrants will have an exercise price of $0.48 per underlying share of Common Stock. Canaccord Genuity is acting as sole book-running …
einnews.com
OFF
BioXcel Therapeutics Announces Pricing Of $7.0 Million Public …
6 days from now
21 hours ago · BioXcel Therapeutics Announces Pricing of $7.0 Million Public Offering ... today announced the pricing of an underwritten public offering of 5,600,000 shares of its common …
streetinsider.com
OFF
BioXcel Therapeutics Announces Pricing Of $7.0 Million Public …
6 days from now
21 hours ago · NEW HAVEN, Conn., Nov. 22, 2024 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (the "Company”) (Nasdaq: BTAI), a biopharmaceutical company utilizing …
manilatimes.net
OFF
BioXcel Therapeutics Reports Third Quarter 2024 Financial Results
6 days from now
Nov 14, 2024 · NetLoss: BioXcel Therapeutics had a net loss of $13.7 million for the third quarter of 2024, compared to a net loss of $50.5 million for the same period in 2023. The Company …
businessinsider.com
FAQs about BioXcel Therapeutics Announces Pricing of $7.0 Million Public … Coupon?
Is bioxcel Therapeutics a biopharmaceutical company?
What time will bioxcel Therapeutics' financial results be released?
How much money did bioxcel Therapeutics make in 2024?
Who owns bioxcel Therapeutics (btai)?
How do I contact bioxcel Therapeutics?
How do I access a live call from bioxcel Therapeutics?
Install CouponFollow Extension on Chrome
Install the CouponFollow extension to search for discount codes when shopping the fastest!
Install CouponFollow Chrome Extension
Listing Store by Characters
